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ABSTRACT
CARSWELL, A. T., S. J. OLIVER, L. M. WENTZ, D. S. KASHI, R. ROBERTS, J. C. TANG, R. M. IZARD, S. JACKSON, D.
ALLAN, L. E. RHODES, W. D. FRASER, J. P. GREEVES, and N. P. WALSH. Influence of Vitamin D Supplementation by Sunlight or
Oral D3 on Exercise Performance. Med. Sci. Sports Exerc., Vol. 50, No. 12, pp. 2555–2564, 2018. Purpose: To determine the relationship
between vitamin D status and exercise performance in a large, prospective cohort study of young men and women across seasons (study 1).
Then, in a randomized, placebo-controlled trial, to investigate the effects on exercise performance of achieving vitamin D sufficiency (serum
25(OH)D Q 50 nmolILj1) by a unique comparison of safe, simulated-sunlight and oral vitamin D3 supplementation in wintertime (study 2).
Methods: In study 1, we determined 25(OH)D relationship with exercise performance in 967 military recruits. In study 2, 137 men received
either placebo, simulated sunlight (1.3 standard erythemal dose in T-shirt and shorts, three times per week for 4 wk and then once per week
for 8 wk) or oral vitamin D3 (1000 IUId
j1 for 4 wk and then 400 IUIdj1 for 8 wk). We measured serum 25(OH)D by high-pressure liquid
chromatography tandem mass spectrometry and endurance, strength and power by 1.5-mile run, maximum dynamic lift and vertical jump,
respectively. Results: In study 1, only 9% of men and 36% of women were vitamin D sufficient during wintertime. After controlling for body
composition, smoking, and season, 25(OH)D was positively associated with endurance performance (P e 0.01, $R2 = 0.03–0.06, small f 2
effect sizes): 1.5-mile run time was ~half a second faster for every 1 nmolILj1 increase in 25(OH)D. No significant effects on strength or
power emerged (P 9 0.05). In study 2, safe simulated sunlight and oral vitamin D3 supplementation were similarly effective in achieving
vitamin D sufficiency in almost all (97%); however, this did not improve exercise performance (P 9 0.05).Conclusions: Vitamin D status
was associated with endurance performance but not strength or power in a prospective cohort study. Achieving vitamin D sufficiency via
safe, simulated summer sunlight, or oral vitamin D3 supplementation did not improve exercise performance in a randomized-controlled
trial. Key Words: CHOLECALCIFEROL, 25-HYDROXYVITAMIN D, UVB, ENDURANCE, STRENGTH, POWER
V
itamin D can be obtained from dietary sources but is
primarily synthesized by skin exposure to sunlight
ultraviolet B (UVB) radiation. Those who live at lati-
tudes 935- or live indoors for the majority of sunlight hours and
cover-up from the sun are at higher risk for vitamin D insuffi-
ciency (serum 25-hydroxyvitamin D (25(OH)D) G 50 nmolILj1
(1,2)). Avoiding low serum 25(OH)D is essential for mus-
culoskeletal health with current Institute of Medicine (IOM)
and European Food Safety Authority (EFSA) recommendations
to maintain serum 25(OH)D concentration Q 50 nmolILj1 (3,4).
Vitamin D stimulates skeletal muscle protein synthesis via
vitamin D receptor–mediated signaling (5) and may improve
cardiac and endothelial function (6,7); as such, avoiding low
serum 25(OH)D and achieving vitamin D sufficiency may
be important for both strength and endurance type exercise
(1,8). Positive associations between vitamin D status and
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physical performance have been reported in studies with
elderly participants (9); for example, correcting vitamin D
deficiency (serum 25(OH)D G 30 nmolILj1) has been shown
to increase strength in the elderly (10). Whether vitamin D
has measurable and meaningful effects on exercise perfor-
mance in young otherwise healthy adults is a matter of
continued debate (11). Cross-sectional studies investigating
the influence of vitamin D status on exercise performance in
young healthy adults often present conflicting findings (12);
likely contributing factors include small samples sizes and a
lack of control over variables that may influence exercise per-
formance (i.e., age, sex, body composition, smoking, physical
activity and season) (8,13,14). Interpreting the findings from
vitamin D supplementation studies is also challenging (11).
The participant populations in some supplementation studies
were vitamin D sufficient at baseline (15,16), and studies have
used greater than currently recommended oral and ultraviolet
radiation (UVR) doses; raising the risk of vitamin D toxicity
(15,17,18) (tolerable upper intake 4000 IUIdj1) (3,4) and
sunburn, which is a risk factor for skin cancer (19). Claims
have been made of benefits to exercise performance in early
UVR studies using sun lamps (8), including purported benefits
of UVR for cardiovascular fitness and local muscular endurance
(20). Although intriguing, these claims should be interpreted
with due caution as the studies involved were not placebo-
controlled and they made no assessment of serum 25(OH)D
(20). As such, randomized, placebo-controlled trials investi-
gating the influence of recommended oral vitamin D supple-
mentation and safe simulated sunlight exposure on vitamin D
status and exercise performance are required.
Here we present results from a prospective cohort study
conducted during all seasons (study 1) and a randomized,
placebo-controlled supplementation study that commenced
in the UK winter, when vitamin D status was at its nadir
(study 2). In study 1, we examined the relationship between
serum 25(OH)D and endurance, strength, and power exercise
performance in 967 young, healthy men and women, after
adjusting for variables considered to influence exercise per-
formance (e.g., body composition, smoking, and season). In
study 2, we determined the effect of 12 wk vitamin D sup-
plementation, by either simulated sunlight in accordance with
recommendations on safe, casual sunlight exposure (21), or oral
vitamin D3, on serum 25(OH)D and exercise performance.
We hypothesized that wintertime vitamin D supplementation
achieving vitaminD sufficiency (serum25(OH)D Q 50 nmolILj1)
would improve exercise performance.
METHODS
Studies received ethics approval from the UK Ministry of
Defence Research Ethics Committee and were conducted in
accordance with the Declaration of Helsinki (2013). British
Army recruit volunteers participated in study 1 and study 2
after providing fully informed written consent and passing a
physician-screened medical assessment. Men (study 1 and
study 2) were located at Infantry Training Centre Catterick,
UK (latitude, 54-N) and women (study 1) were located at Army
Training Centre Pirbright, UK (latitude, 51-N). All volunteers
were studied during Basic Military Training that follows a
generic syllabus of basic military skills including physical
training, weapon handling, map reading, and field craft. The
progressive, structured, physical training program included:
endurance training, typically involving running in groups, with
and without load carriage; circuit training, consisting of high-
repetition, low force exercises using all major muscle groups;
agility based gymnasium work using benches and ropes; and
assault course practice. Marching with various loads while on
military exercise and military drill were also undertaken.
Study 1
Participants and study design. Nine hundred sixty-
seven men and women (age, 22 T 3 yr; 95% white ethnicity; n =
621 men: body mass, 75.0 T 10.0 kg; height, 1.78 T 0.06 m; body
mass index (BMI), 23.8 T 2.8 kgImj2; body fat, 19.8 T 5.3%;
current smokers, 45%; n = 346women: bodymass, 63.9 T 7.9 kg;
height, 1.65 T 0.06 m; BMI, 23.4 T 2.4 kgImj2; body fat, 30.2 T
4.9%; current smokers, 25%) participated in this prospective co-
hort study between January 2014 and September 2015.
Experimental procedures. We collected baseline mea-
surements from each participant during week 1 of training; in-
cluding a venous blood sample for the determination of serum
25(OH)D; body composition by dual-energy x-ray absorptiom-
etry (DXA) (Lunar iDXA; GE Healthcare, Buckinghamshire,
UK); ethnicity and smoking history by questionnaire; and exer-
cise performance. During the DXA participants were instructed
to lie motionless in the supine position for the duration of the
scan, with straps fitted around their lower limbs to minimize
movement. Men wore only underwear, and women wore light
clothing. The DXA scanner was calibrated eachmorning before
use. To assess endurance exercise performance, the time to
complete a best effort 1.5-mile run on an outdoor course was
recorded to the nearest second. The 1.5-mile run is used widely
among military personnel, with performance indicative of an
individual_s maximal aerobic capacity (22). Participants were
highly motivated because their best effort was required for
progression in their military careers. We determined maximum
strength as the maximal weight lifted on a machine that sim-
ulates a power clean weightlifting movement, as described
previously (23). Explosive power was assessed by counter-
movement jump using a jump mat (Takei Scientific Instruments,
Tokyo, Japan), as described (23), along with the following
validated equation: explosive power (W) = (51.9  maximal
vertical jump height (cm)) + (48.9 body mass (kg))j 2007
(24). Participants were instructed to jump as high as possible
three times, with their hands placed on their hips to prevent
upper limb assistance. Where an increase in jump height oc-
curred across jumps 1 to 3, indicative of a learning effect, a
fourth jump was made. Maximal vertical jump height was
recorded as the highest score achieved. Test–retest reliability
of r Q 0.90 has been reported for these performance tests (23).
After 12 wk of training, a cohort of 331 participants (170 men
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and 161 women) repeated baseline measurements; these partici-
pants were randomly selected throughout the year to provide a full
seasonal spread for follow-up measurements. In addition, medical
records were accessed to calculate the number of incomplete
training days due to illness or injury for each participant.
Study 2
Participants and study design. Men were eligible to
participate in this double-blind, randomized, placebo-
controlled trial if they had sun-reactive skin types I to IV (25);
were not currently consuming supplements containing vita-
min D; and had not used a sun bed or travelled to a sunny
climate in the 3 months before the study. The study took place
in 2016 and 2017, with participants commencing in January or
February when ambient UVB was negligible at UK latitudes.
One hundred thirty-seven men completed the 12-wk inter-
vention with a compliance Q80% (100% white ethnicity; age,
22 T 3 yr; body mass, 77.0 T 11.5 kg; height, 1.77 T 0.06 m;
BMI, 24.4 T 2.8 kgImj2; body fat, 21.5% T 5.3%; current
smokers, 34%). There were no differences between treatment
and control groups for demographics, anthropometrics and
serum vitamin D metabolites at baseline.
Experimental procedures. Participants were block ran-
domized within their platoons to one of four, 12-wk interven-
tion groups: 1) solar-simulated radiation (SSR); 2) SSR placebo
(SSR-P); 3) oral vitaminD3 (ORAL); or 4) oral placebo (ORAL-P).
Block randomization (using randomizer.org) resulted in an
equal distribution of intervention groups within each platoon,
and therefore ensured any differences in training conditions
between platoons did not influence the study outcomes. The
intervention strategy for the SSR and ORAL groups was to
restore and then maintain IOM and EFSA recommended
vitamin D sufficiency (serum 25(OH)D Q 50 nmolILj1).
Participants completed a 4-wk restoration phase, necessary
because 25(OH)Dwas at its winter nadir, followed by an 8-wk
maintenance phase (Fig. 1). Before and after the restoration
and maintenance phases, exercise performance was assessed
using identical procedures to study 1 and a venous blood sam-
ple was collected for the determination of serum vitamin D
metabolites. Vitamin D from the diet was estimated in week 12
using a food frequency questionnaire, and solar UVR exposure
was measured in weeks 4 and 11 using polysulphone badges
(26). Dietary vitamin D intake was then calculated, excluding
that which participants in the ORAL group received from their
intervention. On completion of the study, participants were
asked to guess which intervention, that is, active or control, they
thought they had been receiving.
Simulated sunlight. Simulated sunlight was provided
in accordance with guidelines on safe sunlight exposure for
vitamin D synthesis (21); described previously to achieve
serum 25(OH)D Q 50 nmolILj1 in the majority of white
skinned persons (19). Those assigned to the SSR intervention
were exposed three times a week during the restoration phase
to an experimenter-controlled constant UVR dose using a
whole body irradiation cabinet (Hapro Jade, Kapelle, the
Netherlands) fitted with ArimedB fluorescent tubes (Cosmedico,
Stuttgart, Germany). The fluorescent tubes emitted a UVR
spectrum similar to sunlight (L, 290–400 nm; 95% UVA,
320–400 nm; 5% UVB, 290–320 nm) that was characterized
by a spectroradiometer (USB2000+; Ocean Optics BV, Duiven,
the Netherlands) radiometrically calibrated with traceability to
UK national standards. During each exposure, participants
received a 1.3 standard erythemal dose (SED), whereas
wearing shorts and T-shirt to expose ~40% skin surface area.
This dose is equivalent to ~15 min, midday summer sun ex-
posure six times per week for a casually dressed individual in
northern England (latitude 53.5-N) (19), and taking account
of pre–vitamin D irradiance at different latitudes, can be
related to exposure times at other world locations (27). For
example, the equivalent exposure time in Philadelphia,
Pennsylvania (40-N) would be ~12 min; and that for Oslo,
FIGURE 1—Schematic of study 2 procedures, to investigate the effect of vitamin D supplementation by SSR, oral vitamin D3 (ORAL), or placebo (SSR-P or
ORAL-P) on exercise performance (1.5-mile run, maximum dynamic lift strength and explosive power), using a 4-wk restoration phase followed by an 8-wk
maintenance phase. Syringe icon represents blood sample; running icon represents 1.5-mile run; weightlifting icon represents maximum dynamic lift strength;
jumping icon represents explosive power; PSF, polysulphone badge; FFQ, food frequency questionnaire.
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Norway (60-N) would be ~18 min. During the maintenance
phase, we exposed SSR participants to the same 1.3 SED dose
only once a week: pilot investigations confirmed the required
dose to maintain sufficiency (serum 25(OH)D Q 50 nmolILj1).
A constant SSR dose was maintained during the study by
monitoring irradiance using a spectroradiometer (USB2000+;
Ocean Optics BV) and adjusting for any decrease in measured
irradiance emitted by increasing exposure time, as described
(19) (mean duration of SSR exposures was 222 T 23 s). We
controlled the exposure time by using an electronic timer on
the irradiation cabinet. For the SSR-P participants the number
of intervention exposures each week and the exposure du-
ration were the same as SSR except the irradiation cabinet
fluorescent tubes were covered with transparent UVR
blocking film (DermaGard UV film; SunGard,Woburn, MA).
Spectroradiometry confirmed the UVR blocking film was
effective at preventing transmission of 99.9% of UVR.
Oral vitamin D3. Participants receiving the ORAL inter-
vention consumed a vitamin D3 capsule daily, containing a
1000 IU dose during the restoration phase and a 400 IU dose
during the maintenance phase (Pure Encapsulations, Sudbury,
MA). The restoration dose was based on previous predictive
modeling to achieve serum 25(OH)D Q 50 nmolILj1 (28),
and pilot investigations that showed it achieved similar serum
25(OH)D concentrations to SSR; and was less than the toler-
able upper intake recommended by the IOM and EFSA (3,4).
The ORAL maintenance dose was also in accordance with
recommendations (3,29). For 12 wk, ORAL-P participants
consumed an identical looking cellulose placebo capsule daily
(Almac Group, County Armagh, UK). Independent analysis
found the vitamin D3 content of the 1000 and 400 IU capsules
to be 1090 and 460 IU, respectively and confirmed the pla-
cebo did not contain vitamin D (NSF International Labora-
tories, Ann Arbor, MI).
Blood collection and analysis. Whole blood samples
were collected by venepuncture from an antecubital vein into
plain vacutainer tubes (Becton Dickinson, Oxford, UK) and
left to clot for 1 h. Subsequently, samples were centrifuged at
1500g for 10 min at 4-C and the serum aliquoted into universal
tubes before being immediately frozen at j80-C for later
analysis. Total serum 25(OH)D was measured with high-
pressure liquid chromatography tandem mass spectrometry;
and serum 1,25-dihydroxyvitamin D (1,25(OH)2D; study 2)
using the DiaSorin LIAISON XL 1,25(OH)2D chemilumi-
nescent immunoassay (Stillwater, Minnesota, USA) method.
Analyses were performed in a Vitamin D External Quality
Assurance Scheme certified laboratory (Bioanalytical Facility,
University of East Anglia, Norwich, UK).
Statistical analysis. In study 1, hierarchical multiple lin-
ear regression was used to determine the association between
25(OH)D and exercise performance at baseline and follow-up.
For the 1.5-mile run, fat mass, smoking and season were
included as covariates (8,13,14). For maximum dynamic lift
strength and explosive power, covariates were lean body
mass, smoking, height and season (8). Follow-up regression
models included baseline covariates with the addition of
incomplete training days to control for injury and illness
(30,31). For these analyses, we estimated a minimum sample
size of 155 using effect sizes from a previous study (32) and
standard formula (n Q (8 / f 2) + (number of predictors j 1))
(33). We completed final analyses on 967 participants after
removing 2 men with z-scores Q99.9th percentile for baseline
25(OH)D and 1.5-mile run time. We calculated Cohen_s f 2
effect size for 25(OH)D using standard formula (34). We also
compared exercise performance between baseline serum
25(OH)D quartiles using one-way ANOVA, and calculated
Cohen_s d effect size (34). To correct the positive skew of
variables not normally distributed, we log or square root
transformed fat mass, lean body mass and serum 25(OH)D,
where necessary. As required, we corrected the negative skew
of 1.5-mile run time using a cube transformation. We used
paired-sample t-tests to compare exercise performance be-
tween baseline and follow-up. In study 2, we used mixed
model ANOVA to compare vitamin D metabolites and exer-
cise performance between vitamin D supplementation (SSR
and ORAL combined together) and placebo groups. A sample
size estimation for this analysis indicated that 19 participants
per group were required to produce an 80% chance of obtaining
statistical significance at the 0.05 level, based on the effect size
( f = 0.175) and correlation between repeated measures (r =
0.67) determined from study 1 run time data (G*Power,
version 3.1.9.2). In addition, we compared individual active
interventions to their respective placebos (SSR vs SSR-P;
and ORAL vs ORAL-P) by mixed model ANOVA. Where
statistically significant interactions were found, simple main
effects were explored with one-way repeated-measures
ANOVA and independent t-tests. Statistical analyses were
performed using SPSS Statistics 22.0 (IBM, Armonk, NY).
Statistical significance was accepted at P G 0.05.
RESULTS
Study 1
Exercise performance. For participants who com-
pleted measures at baseline and follow-up, 1.5-mile run time
was faster at follow-up (men 627 T 48 vs 578 T 31 s; women
699 T 54 vs 667 T 44 s; P G 0.001). Maximum dynamic lift
strength decreased in men (71 T 12 kg vs 68 T 11 kg; P G 0.01)
but did not change in women (43 T 9 kg vs 44 T 9 kg; P 9
0.05). From baseline to follow-up, explosive power decreased
in men (3868 T 619 W vs 3797 T 573 W; P G 0.01) but in-
creased in women (2766 T 465W vs 2840 T 436W; P G 0.01).
Low vitamin D status during winter. Baseline winter
serum 25(OH)D was lower than all other seasons in men and
lower than summer and fall in women (P G 0.001; Fig. 2A).
During winter, only 9% of men and 36% of women were vita-
min D sufficient (baseline 25(OH)D Q 50 nmolILj1; Fig. 2B).
Vitamin D status predicts endurance exercise
performance. Using hierarchical multiple linear regression,
serum 25(OH)D predicted endurance exercise performance
after controlling for fat mass, smoking, and season; baseline
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serum 25(OH)D accounted for 4% and 6% of the variance in
1.5-mile run time in men and women, respectively (Table 1).
Every 1 nmolILj1 increase in 25(OH)D translated into 0.42 T
0.16 s faster (T95% CI) 1.5-mile run time in men and 0.57 T
0.25 s faster 1.5-mile run time in women. Although statistically
significant, the small Cohen_s f 2 effect sizes indicate the
magnitude of additional variance explained in endurance
performance by serum 25(OH)D is relatively small (Table 1).
These relationships were not reliant on participants with high or
low 25(OH)D concentrations because positive associations
remained after removingmen andwomenwith 25(OH)D Q 75 or
G30 nmolILj1 (P G 0.05). At follow-up, after 12 wk of
training, 25(OH)D was again positively associated with en-
durance exercise performance, irrespective of whether the
number of incomplete training days was included in the
model; 25(OH)D explained 6% and 3% of the variance in
1.5-mile run time in men and women, respectively, after
controlling for fat mass, smoking, season, and the number of
incomplete training days (Table 1). Using a simple one-way
ANOVA, that is, without control for body composition,
smoking and season, 1.5-mile run time was fastest among
men with baseline serum 25(OH)D in the highest quartile
(975 nmolILj1, P G 0.05, Cohen_s d effect size = 0.4); a
similar trend was observed in women (Fig. 2C, P G 0.1;
Cohen_s d effect size = 0.4).
Vitamin D status was not associated with strength
or power exercise performance. Serum 25(OH)D was
not significantly associated with maximum dynamic lift
strength, or explosive power in men or women after con-
trolling for lean mass, smoking, height and season (P 9
0.05). At follow-up, once again 25(OH)D was not associ-
ated with maximum dynamic lift strength, or explosive
power in men or women (P 9 0.05). Analyzing quartiles of
baseline serum 25(OH)D using simple one-way ANOVA,
there were no differences in maximum dynamic lift strength
or explosive power (P 9 0.05).
Study 2
During the 12-wk intervention, daily sunlight exposure
(0.22 T 0.33 SEDIdj1; P 9 0.05) and daily dietary vitamin D
intake were not different between groups (120 T 88 IUIdj1,
P 9 0.05). Participants were sufficiently blinded to the in-
tervention since only 35% correctly guessed their allocated
group, 32% were incorrect, and 33% said they did not know
whether they had received an active or placebo intervention.
Safe simulated sunlight and oral vitamin D3 restored
vitamin D sufficiency in almost all. At baseline, ap-
proximately three quarters (74%) of volunteers were vitamin
D insufficient (serum 25(OH)D G 50 nmolILj1) and ap-
proximately one third (31%) were vitamin D deficient (serum
FIGURE 2—Seasonal variation in serum 25(OH)D (panel A) and per-
centage of participants categorized as vitamin D sufficient (serum 25(OH)D Q
50 nmolILj1; panel B); and 1.5-mile run time by serum 25(OH)D
quartiles (panel C) in 967 healthy, youngmales (n = 621) and females (n =
346) residing in the UK. a, lower than summer (P G 0.05). b, lower than fall
(P G 0.05). c, lower than spring (P G 0.05). §, faster than quartiles 1, 2 and 3
(P G 0.05). Panel A and C data are mean T SD.
TABLE 1. Serum 25(OH)D predicts 1.5-mile run time after controlling for fat mass, smoking,
and season, plus incomplete training days at follow-up.
R2
Overall $R2
Sig. F
Change
Standardized
Beta Cohen’s f2
Males
Baseline 0.20 0.04 G0.001 j0.24 0.04
Follow-up 0.29 0.06 0.002 j0.32 0.09
Follow-up
(incomplete training
days added)
0.30 0.06 0.002 j0.33 0.09
Females
Baseline 0.34 0.06 G0.001 j0.26 0.08
Follow-up 0.37 0.04 0.007 j0.23 0.06
Follow-up
(incomplete training
days added)
0.39 0.03 0.013 j0.22 0.05
Cohen’s f 2 Q 0.02, Q 0.15 and Q 0.35 represent small, medium and large effect sizes,
respectively (33).
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25(OH)D G 30 nmolILj1). Both SSR and ORAL supple-
mentation were successful strategies to achieve vitamin D
sufficiency and maintain serum 25(OH)D concentrations so
that at weeks 5 and 12 serum 25(OH)D concentrations in the
SSR and ORAL groups were higher than their respective pla-
cebo groups (P G 0.001; Fig. 3). Indeed, by week 5, almost all
SSR and ORAL participants were vitamin D sufficient (97%:
serum 25(OH)D Q 50 nmolILj1), and none were vitamin D
deficient (serum 25(OH)D G 30 nmolILj1); additionally,
more than half (59%) had achieved the proposed optimal
serum 25(OH)D Q 75 nmolILj1 (1,2,35). Serum 1,25(OH)2D
increased from baseline in the SSR and ORAL groups (P G
0.05; Fig. 4), and was higher than placebo groups at week 5
(P G 0.05). There was no difference between groups at week
12 (P 9 0.05) because serum 1,25(OH)2D increased from
weeks 5 to 12 in the placebo groups (P G 0.01).
Safe simulated sunlight and oral vitamin D3 did
not affect exercise performance. Vitamin D supple-
mentation that achieved vitamin D sufficiency in almost all
participants did not affect 1.5-mile run time, maximum dy-
namic lift strength or explosive power (Table 2, all interac-
tion P values 90.05). Furthermore, participants on SSR and
ORAL that achieved the proposed optimal vitamin D status
(serum 25(OH)D Q 75 nmolILj1) by week 5 did not improve
their 1.5-mile run time more than those who received placebo
and remained vitamin D insufficient (1.5-mile run time im-
provement by week 5: participants Q75 nmolILj1; j28 T 32 s
vs participants on placebo and G 50 nmolILj1; j24 T 34 s,
P 9 0.05, Cohen_s d effect size = 0.1). Additionally, those
who achieved proposed optimal vitamin D status by week
12 did not improve their 1.5-mile run time, maximum dy-
namic lift strength or explosive power more than those who
FIGURE 3—Serum 25(OH)D and percentage of participants categorized as vitamin D sufficient (serum 25(OH)D Q 50 nmolILj1) in response to 12 wk of
vitamin D supplementation by SSR and oral vitamin D3 (ORAL). Panels A and B show combined active interventions (SSR and ORAL) vs combined
placebo (SSR-P and ORAL-P), panels C and D show SSR vs SSR-P, and panels E & F show ORAL vs ORAL-P. †††P G 0.001, greater than baseline.
‡‡‡P G 0.001, greater than week 5. *P G 0.05 and ***P G 0.001, greater than placebo. Data in panels A, C, and E are mean T SD.
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remained vitamin D insufficient (P 9 0.05). As expected,
1.5-mile run time improved during training; however, ex-
plosive power decreased during training (Table 2, main
effect of time; P G 0.01).
DISCUSSION
Primary Findings and Strengths
In study 1, in 967 young, healthy military recruits, we showed
there was no influence of vitamin D status on muscular strength
and power; however, a novel finding was that serum 25(OH)D
was positively associatedwith endurance running performance in
both men and women (Table 1). The findings of study 1 can be
considered robust as they were observed in men and women;
after controlling for body composition, smoking, and season;
and after removing those with low or high vitamin D status
(serum 25(OH)D G 30 or Q 75 nmolILj1). Study 1 is the first to
control for body composition in regression models investigating
the relationship between vitamin D status and endurance run-
ning performance. Controlling for body composition is impor-
tant because excess adipose tissue sequesters vitamin D; hence,
individuals with high fat mass have lower serum 25(OH)D
concentrations (36). High fat mass impairs exercise perfor-
mance in young adults (13); consequently, high body fat and
low availability of vitamin D may be responsible for poor
performance in individuals with insufficient serum 25(OH)D
concentrations. We have additional confidence in study 1
findings because the relationships were observed at the start of
training and again after 12 wk of training; both before and
after taking account of incomplete training days due to illness
and injury (Table 1). In terms of practical significance, the
magnitude of the association between serum 25(OH)D and
endurance performance in study 1 can be considered small
(Cohen_s f 2 effect sizes G0.15). Nevertheless, in real-world
terms, 1.5-mile run time was ~half-a-second faster for every
1 nmolILj1 increase in serum 25(OH)D in men and women;
equating to an ~20 s improvement in 1.5-mile run time for a
40 nmolILj1 increase in serum 25(OH)D.
Given the low prevalence of vitamin D sufficiency during
wintertime in study 1 (only 9% of men and 36% of women
were vitamin D sufficient; Fig. 2B), in study 2, we explored
the possibility that achieving vitamin D sufficiency from
its wintertime nadir would enhance exercise performance.
Study 2 involved a unique comparison of safe, simulated,
casual skin sunlight exposure and oral vitamin D3 supple-
mentation specifically designed to achieve vitamin D suf-
ficiency. Contrary to our hypothesis, achieving andmaintaining
IOM and EFSA defined vitamin D sufficiency in 97% of
participants, who received vitamin D supplementation
(Fig. 3), did not benefit endurance, strength or power exercise
performance (Table 2).
Vitamin D and Exercise Performance
Previous research relying on cross-sectional designs that
did not control for important confounders (e.g., body com-
position) may have overestimated the influence of vitamin D
on exercise performance (8,12). Consistent with this notion,
in study 1, we show that endurance performance was best in
those with proposed optimal serum 25(OH)D Q 75 nmolILj1
(Fig. 2C) (1,2,35). Our randomized placebo-controlled trial in
contrast showed no beneficial effect of achieving vitamin D
sufficiency on exercise performance. Furthermore, in ~60%
of our participants, vitamin D supplementation achieved the
proposed optimal serum 25(OH)D Q 75 nmolILj1 but this did
not lead to improved exercise performance. These findings
agree with other randomized, controlled trials suggesting that
oral vitamin D supplementation does not directly benefit
exercise performance (15,17,37). We add to this body of work
by showing that exercise performance is not improved when
vitamin D status is increased by oral vitamin D3 or UVB sup-
plementation. Although supplementation restored vitamin D
sufficiency, the relatively small increase in serum 1,25(OH)2D
(Fig. 4) could conceivably account for the absence of a bene-
ficial effect on exercise performance. Whether larger vitamin D
FIGURE 4—Serum 1,25(OH)2D in response to 12 wk of vitamin D
supplementation by SSR and oral vitamin D3 (SSR and ORAL) vs
placebo (SSR-P and ORAL-P). †P G 0.05 and ††P G 0.01, greater than
baseline. ‡‡P G 0.01, greater than week 5. *P G 0.05, greater than placebo.
Data are mean T SD.
TABLE 2. Influence of 12-weeks solar-simulated radiation (SSR), placebo solar-simulated radiation (SSR-P), oral vitamin D3 (ORAL), and oral placebo (ORAL-P) on exercise performance.
SSR SSR-P ORAL ORAL-P
1.5-mile run time (s) Baseline 616 T 34 633 T 47 636 T 42 631 T 61
$Baseline to week 5* j20 T 24 j14 T 35 j32 T 37 j28 T 40
$Baseline to week 12* j40 T 25 j33 T 38 j49 T 42 j54 T 42
Maximum dynamic lift strength (kg) Baseline 70 T 13 71 T 12 68 T 12 76 T 13
$Baseline to week 12 j1 T 9 j1 T 7 +1 T 8 j3 T 7
Explosive power (W) Baseline 3888 T 704 3930 T 609 3808 T 663 3911 T 633
$Baseline to week 12** j96 T 306 j33 T 332 j43 T 345 j62 T 322
Interaction P 9 0.05, SSR and ORAL vs SSR-P and ORAL-P. Main effect of time vs baseline.
*P G 0.001 and **P G 0.05.
Data are mean T SD.
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doses, achieving greater than normal seasonal changes in serum
25(OH)D (e.g., 9 100 nmolILj1), would have beneficial effects
on exercise performance remains unclear. Although this may
appear to be the logical next step in supplementation studies,
larger vitaminDdosesmay be ineffective because theywill increase
serum 24,25-dihydroxyvitamin D (24,25(OH)2D) concentrations,
which may impair vitamin D receptor–1,25(OH)2D–mediated
adaptations beneficial for exercise performance (11,38).
Moreover, higher doses of simulated sunlight and oral vitamin
D3 in excess of tolerable upper intakes (4000 IUId
j1) risk
skin damage and vitamin D toxicity, respectively (3,21).
We recognize that the positive association between
vitamin D status and endurance performance in study 1 may
be at least partly explained by reverse causation: individuals
with greater long-term physical activity are more likely to
have greater aerobic fitness, spend more time outdoors ex-
posed to sunlight and, in-turn, have higher serum 25(OH)D. A
limitation of study 1 is that we did not account for long-term
physical activity in our regression model. If serum 25(OH)D
concentration in study 1 was reflective of an individual_s long-
term vitamin D status, it may be that long-term vitamin D
sufficiency is necessary for optimal endurance performance.
Therefore, 12 wk of vitamin D supplementation in study 2 may
have been an inadequate duration to benefit exercise perfor-
mance. In accordance with this notion, an extended period of
vitamin D supplementation improved skeletal muscle remod-
eling in untrained, young men during a progressive resistance
training program (39). However, the reported benefits of
longer-term vitamin D supplementation on skeletal muscle
remodeling did not translate to improved muscular strength
(39). A further limitation of both study 1 and study 2 was that
exercise performance was assessed using relatively simple
exercise tests in the field environment. Notwithstanding, the
strength of these tests is that they are functionally relevant for
athletic and military performance, involving multiple joints
working in synergy, and have been shown to predict func-
tional task success and injury risk (22). Participants_ perfor-
mance on the tests was also typical of recruits who had
passed military entry standards, and directly relevant to
young, physically active adults. Further research is
recommended to confirm our findings in elite athletes. A
limitation of study 2 is that we only tested men; it was rea-
soned that vitamin D supplementation would most likely
benefit exercise performance in men because vitamin D in-
sufficiency was more prevalent in men than women in study 1.
We also acknowledge that study 2 findings for SSR are only
relevant to those with Fitzpatrick sun-reactive skin type I–IV
(white skin) and not sun-reactive skin type V or VI (brown or
black skin): serum 25(OH)D response to SSR in sun-reactive
skin type V has been shown to be approximately half that
achieved in those with sun-reactive skin type I–IV (40).
Exposure to springtime ambient UVB in study 2 caused
serum 25(OH)D to increase in the placebo groups at week
12 (Fig. 3). However, we demonstrated that exposure to
ambient UVB was not different between groups, and no effect
of vitamin D supplementation on exercise performance was
seen when vitamin D–sufficient placebo group participants
were removed from analyses.
Perspectives
The American College of Sports Medicine_s recent nutrition
and athletic performance position stand called for research to
investigate vitamin D_s potentially important influence on ex-
ercise performance; facilitating the determination of optimal
vitamin D thresholds and supplementation recommendations
(1). Our finding that vitamin D supplementation, even that which
achieves the proposed optimal serum 25(OH)D Q 75 nmolILj1,
has no beneficial effect on exercise performance is therefore
timely and has important implications for future nutrition and
athletic performance recommendations. Despite evidence
indicating that vitamin D supplementation does not benefit
exercise performance, avoiding low serum 25(OH)D is con-
sidered important for musculoskeletal health (3,4,29). Vitamin D
insufficiency is widespread in athletes and nonathletes (1,2).
Correcting vitamin D insufficiency may also optimize training
availability in athletes and military personnel by increasing re-
sistance to upper respiratory tract infections (41) and reducing
risk of injury (30). Our vitamin D supplementation strategies
were effective in eliminating vitamin D deficiency and achieving
vitamin D sufficiency in almost all. Future studies could use
these methods to investigate the potential benefits of vitamin D
supplementation on immune health and bone health; and the
possible benefits of longer-term vitamin D supplementation.
Rather than restoring vitamin D sufficiency from its winter
nadir, as in study 2, studies should investigate the effect of
preventing the decline in end of summer serum 25(OH)D by
commencing vitamin D supplementation in late summer or
early fall and continuing until spring (~6 months).We propose
the 400 IUIdj1 oral vitamin D3 dose from the maintenance
phase of study 2 for the purpose of maintaining end of sum-
mer vitamin D sufficiency: this oral vitamin D3 supplemen-
tation approach corresponds with current IOM and EFSA
recommendations (3,4). Oral vitamin D3 supplementation is
recommended for this purpose because unlike simulated sun-
light, there is no time burden for an individual; no requirement
for bulky irradiation cabinets; and oral vitamin D3 supplemen-
tation is effective regardless of sun-reactive skin type (40). Studies
are also required to further our understanding of how genetic
variation between individuals (e.g. in vitamin D binding pro-
tein) might affect health and exercise performance outcomes to
vitamin D supplementation (11). These studies, particularly those
completed in diverse ethnic samples, should also consider
assessing the bioavailable (free) fraction of vitamin D: health
outcomes such as bone mineral density reportedly relate more
closely to bioavailable vitaminD than to total serum25(OH)D (11).
CONCLUSIONS
Vitamin D status predicted endurance exercise performance,
but not strength or power, in a prospective cohort study of
967 young, healthy men and women after controlling for
body composition, smoking and season. In a randomized,
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placebo-controlled trial, safe simulated summer sunlight or oral
vitamin D3 were effective in achieving clinically important vi-
tamin D sufficiency in almost all. However, vitamin D supple-
mentation did not improve exercise performance, suggesting that
vitamin D does not directly affect exercise performance.
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